Verbrugh H A, Keane W F, Conroy W E, Peterson P K
J Clin Microbiol. 1984 Aug;20(2):199-203. doi: 10.1128/jcm.20.2.199-203.1984.
We determined the ability of Staphylococcus epidermidis, Staphylococcus aureus, and Escherichia coli to survive and grow in peritoneal dialysis fluids from patients undergoing chronic ambulatory peritoneal dialysis. Staphylococci did not survive in commercially available dialysis solutions but grew readily in peritoneal effluents obtained from patients after the dialysis dwell time. The number of CFU doubled 6 and 13 times in 24 h for S. epidermidis and S. aureus, respectively. E. coli grew well in both the pre- and postdialysis peritoneal fluid. Peritoneal macrophages as well as peripheral blood leukocytes inhibited bacterial growth in peritoneal dialysis fluid. However, 10(6) phagocytes per ml were minimally required to obtain a bacteriostatic effect. The addition of serum to peritoneal dialysis fluid increased the antibacterial activity of macrophages and blood leukocytes. The capacity of the aminoglycoside antibiotic tobramycin to reduce bacterial CFU in peritoneal dialysis fluid was only 10% of its bactericidal capacity in standard Mueller-Hinton brush. Peritoneal dialysis fluid had no effect on the antibacterial activity of imipenem.
我们测定了表皮葡萄球菌、金黄色葡萄球菌和大肠杆菌在接受持续性非卧床腹膜透析患者的腹膜透析液中存活及生长的能力。葡萄球菌在市售透析液中无法存活,但在透析驻留时间后从患者获取的腹膜流出液中能轻易生长。对于表皮葡萄球菌和金黄色葡萄球菌,其菌落形成单位(CFU)数量在24小时内分别增加了6倍和13倍。大肠杆菌在透析前和透析后的腹膜液中均生长良好。腹膜巨噬细胞以及外周血白细胞可抑制腹膜透析液中的细菌生长。然而,每毫升10⁶个吞噬细胞对于获得抑菌效果而言是最低需求。向腹膜透析液中添加血清可增强巨噬细胞和血液白细胞的抗菌活性。氨基糖苷类抗生素妥布霉素在腹膜透析液中降低细菌CFU的能力仅为其在标准穆勒 - 欣顿肉汤中的杀菌能力的10%。腹膜透析液对亚胺培南的抗菌活性没有影响。